Earnings Call Excerpt
Amedisys, Inc. (AMED)
Q3 2008 Earnings Call
October 28, 2008, 10:00 am ET
Executives
Kevin LeBlanc – Director of Investor Relations
Bill Borne – Chairman and Chief Executive Officer
Dale Redman – Chief Financial Officer
Larry Graham – President and Chief Operating Officer
Analysts
John Ransom – Raymond James
Art Anderson – Jefferies and Co.
Kevin Elledge – RBC Capital
Darrin Lerrich – Deutsche Bank
Derrick Dagnan – Avondale Partners
Newton Juhng – BB&T Capital Markets
Eric Gommel – Stifel Nicolaus & Company, Inc.
Whit Mayo – Robert W. Baird & Company
Presentation
Operator
Good day and welcome to the Amedisys third quarter 2008 earnings conference call. Today’s conference is being recorded.
At this time I would like to turn the conference over to Mr. Kevin LeBlanc. Please go ahead, sir.
Kevin LeBlanc
Thanks. Good morning and thank you for joining us today for Amedisys investor conference call to discuss this morning’s third quarter 2008 earnings announcement and related matters.
By now you should receive a copy of our earnings press release. If you did not receive the press release you may access it on Investor Relations page on our website at www.amedisys.com.
Joining me on today’s call from Amedisys are Bill Borne, Chairman and Chief Executive Officer, Larry Graham, President and Chief Operating Officer, and Dell Redman, Chief Financial Officer. Also speaking today will be Alice Ann Schwartz, Chief Information Officer and Senior Vice President for Clinical Operations and Jeffrey Jeter, Chief Compliance Officer.
Before we get started with our call, I’d like to remind everyone that any statements made on this conference call today or in our press releases that express a belief, expectation, or intent as well as those that are not historical facts are considered forward-looking statements and are protected under the Safe Harbor of the Private Securities Litigation Reform Act.
These forward-looking statements are based on information available to Amedisys today, and the company assumes no obligation to update these statements as circumstances change. These forward-looking statements may involve a number of risks and uncertainties which may cause the company’s results to differ materially from such statements. These risks and uncertainties include factors detailed in our SEC filings including our forms 10-K and 10-Q.
Also, the company urges caution in considering any current trends or guidance that may be discussed on this conference call. The home health and hospice industry is highly competitive, and trends and guidance are subject to numerous factors, risks, and influences which are described in the company’s reports and registration statements filed with the SEC. The company disclaims any obligations to update information on trends or targets other than in its periodic filings with the SEC. In addition, as required by SEC Regulation G, a reconciliation of any non-GAAP measures mentioned during our call today to the most comparable GAAP measures will be available on our website at www.amedisys.com on the Investor Relations page under the link Press Releases.
- To read the full transcript on Seeking Alpha, click here »
